Literature DB >> 2693963

Cloning and expression of a trypomastigote-specific 85-kilodalton surface antigen gene from Trypanosoma cruzi.

G B Takle1, A Young, D Snary, L Hudson, S C Nicholls.   

Abstract

An 85-kDa trypomastigote-specific surface antigen gene from Trypanosoma cruzi has been identified by screening a genomic library in lambda gt10 with trypomastigote and epimastigote cDNA. The 1.3-kb genomic clone (pTt34) hybridizes to a single trypomastigote mRNA of 3.7 kb and to multiple bands in genomic Southern blots. Dot-blot experiments show that there are 5-10 copies of this sequence per haploid genome, and these are arranged in a non-tandem manner. pTt34 has been expressed as an anthranilate synthetase fusion protein in Escherichia coli, and inclusion bodies have been used to raise antiserum in rabbits. This antiserum immunoprecipitates a cell surface trypomastigote-specific protein of 85 kDa. The DNA and predicted amino acid sequences of pTt34 are given. Four further clones obtained from a PvuII/HpaI partial genomic library in pUC13 have extended the sequence of the 3' end of pTt34; each of these clones has regions of sequence divergence and each could represent a different member of the gene family.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2693963     DOI: 10.1016/0166-6851(89)90102-3

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  9 in total

1.  The sialidase gene from Clostridium septicum: cloning, sequencing, expression in Escherichia coli and identification of conserved sequences in sialidases and other proteins.

Authors:  B Rothe; B Rothe; P Roggentin; R Schauer
Journal:  Mol Gen Genet       Date:  1991-04

2.  The major 85-kDa surface antigen of the mammalian-stage forms of Trypanosoma cruzi is a family of sialidases.

Authors:  S Kahn; T G Colbert; J C Wallace; N A Hoagland; H Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

Review 3.  Pathogenesis of chagas' disease: parasite persistence and autoimmunity.

Authors:  Antonio R L Teixeira; Mariana M Hecht; Maria C Guimaro; Alessandro O Sousa; Nadjar Nitz
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

4.  A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF.

Authors:  D V Tambourgi; T L Kipnis; W D da Silva; K A Joiner; A Sher; S Heath; B F Hall; G B Ogden
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

5.  Characterization of a cDNA clone encoding the carboxy-terminal domain of a 90-kilodalton surface antigen of Trypanosoma cruzi metacyclic trypomastigotes.

Authors:  F R Franco; G S Paranhos-Bacallà; L M Yamauchi; N Yoshida; J F da Silveira
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

6.  Further characterization of protective Trypanosoma cruzi-specific CD4+ T-cell clones: T helper type 1-like phenotype and reactivity with shed trypomastigote antigens.

Authors:  S P Nickell; M Keane; M So
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

7.  Binding of the specific ligand to Fc receptors on Trypanosoma cruzi increases the infective capacity of the parasite.

Authors:  C Rodriguez de Cuna; F Kierszenbaum; J J Wirth
Journal:  Immunology       Date:  1991-01       Impact factor: 7.397

8.  Deletion of a Golgi protein in Trypanosoma cruzi reveals a critical role for Mn2+ in protein glycosylation needed for host cell invasion and intracellular replication.

Authors:  Srinivasan Ramakrishnan; Linn M Unger; Rodrigo P Baptista; Teresa Cruz-Bustos; Roberto Docampo
Journal:  PLoS Pathog       Date:  2021-03-15       Impact factor: 6.823

9.  Only some members of a gene family in Trypanosoma cruzi encode proteins that express both trans-sialidase and neuraminidase activities.

Authors:  H Uemura; S Schenkman; V Nussenzweig; D Eichinger
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.